Entos pharmaceuticals announces launch of us-based spinout company aegis life, inc. to support its global vaccine commercialization strategy

Entos launched aegis life to pursue us-based development and commercialization of a sars-cov-2 vaccine using the entos fusogenix technology.

ASIX Ratings Summary

ASIX Quant Ranking